https://metro.legistar.com/Gateway.aspx?M=LD&From=RSS&ID=6024112&GUID=9F160C1C-4706-469D-B58F-22FE6B61AB03&G=A5FAA737-A54D-4A6C-B1E8-FF70F765FA94Legistar15https://metro.legistar.com/Gateway.aspx?M=LD&From=RSS&ID=6024112&GUID=9F160C1C-4706-469D-B58F-22FE6B61AB03&G=A5FAA737-A54D-4A6C-B1E8-FF70F765FA949F160C1C-4706-469D-B58F-22FE6B61AB03-2025-06-09-07-37-56Title: AUTHORIZE the Chief Executive Officer to award a five-year, firm fixed unit rate Contract No. PS75883000 to Phamatech, Inc. (Phamatech) to provide drug testing laboratory analysis services in an amount not-to-exceed $377,025 for a base term of three years, plus $135,675 for each of the two, one-year option terms for a combined not-to-exceed amount of $648,375, effective April 1, 2023, subject to the resolution of any timely protest(s), if any.Mon, 09 Jun 2025 07:37:56 GMT